Skip to main content
Pain Medicine

Pain Medicine

NEWS | October 29, 2012

"What's Good for the Body is Good for the Brain" the topic of Alzheimer's Disease Center symposium

(SACRAMENTO, Calif.)

The UC Davis Alzheimer's Disease Center will hold its first annual research symposium and poster session titled "What's Good for the Body is Good for the Brain," on Thursday, Nov. 1, from 4 p.m. to 6:30 p.m. in lecture hall 2222 in the Education Building, 4610 X St., Sacramento, Calif.

Charles DeCarli Charles DeCarli

The event will feature welcomes from Chong Porter, associate vice chancellor of Health Sciences Development and Alumni Relations, and Charles DeCarli, director of the Alzheimer's Disease Center. It is being held in recognition of National Alzheimer's Disease Month in November.

Two researchers, Heike Wulff, associate professor in the Department of Pharmacology, and Owen Carmichael, assistant professor in the Department of Neurology, will give brief presentations on their research. Wulff will discuss "Microglial Potassium Channels as Potential Novel Targets for Alzheimer's Disease" at 4:40 p.m., followed by a discussion of "Development of MRI-Based Measures of Local Hippocampus Atrophy" by Carmichael at 4:50 p.m.

DeCarli will then moderate a panel discussion, "What's Good for the Body is Good for the Brain," at 5 p.m. Panelists will include Lars Berglund, director of the UC Davis Clinical and Translational Science CenterJan Nolta, director of the UC Davis Center for Regenerative CuresBruce Reed, associate director of the Alzheimer's Disease Center; and John Rutledge, vice chair of research in the Department of Internal Medicine. The poster session will follow at 5:30 p.m.

The event is sponsored by the Alzheimer's Disease Center, Sunrise Senior Living, the Alzheimer's Aid Society of Northern California, CiminoCare and the Asian Community Center's Bridge to Healthy Families Project. For further information, please contact Jayne La Grande, Alzheimer's Disease Center, at 916-734-5728.

The UC Davis Alzheimer's Disease Center is one of only 29 research centers designated by the National Institutes of Health's National Institute on Aging. The center's goal is to translate research advances into improved diagnosis and treatment for patients while focusing on the long-term goal of finding a way to prevent or cure Alzheimer's disease. Also funded by the state of California, the center allows researchers to study the effects of the disease on a uniquely diverse population. For more information, visit alzheimer.ucdavis.edu.